Quick answer
What should be verified before ordering a research peptide? Ten things: that the exact compound is named with its formula or sequence; that a lot-specific certificate exists and matches the lot on the vial; what the purity figure measures and how; whether identity was confirmed separately from purity; whether endotoxin and sterility testing are reported for products that need them; how the product is supplied and stored; whether the label is consistent with the product page; whether the documentation can be checked independently; how the seller handles questions and discrepancies; and whether the terms are explicitly research use only. A seller that can answer all ten in writing is easy to evaluate. One that cannot is a risk to your data.
Ranking suppliers is a matter of opinion; verifying them is a matter of documents. This checklist turns the buying decision into ten questions you can answer from a product page, a certificate and a short message. It applies equally to a first purchase and to a repeat one. For laboratory research use only; not for human consumption.
The ten checks at a glance
| # | Check | What a good answer looks like | Red flag |
|---|---|---|---|
| 1 | Compound identity | Name, sequence or formula, form and size stated | Brand-style name only, no formula |
| 2 | Lot-specific certificate | Certificate with a lot number matching the vial | One generic certificate for all lots |
| 3 | Purity method | Stated technique (for example HPLC), conditions and detection wavelength | "99%+" with no method |
| 4 | Identity confirmation | A separate identity measurement, not only a chromatogram | Purity presented as identity |
| 5 | Endotoxin and sterility | Reported where relevant to the intended assay | Silent on cell-culture suitability |
| 6 | Form and storage | Lyophilized powder, storage temperature and light protection stated | No storage instruction |
| 7 | Label consistency | Label, page and certificate agree on name, size and lot | Mismatches between them |
| 8 | Independent verifiability | Testing laboratory and report can be identified | Unverifiable screenshots |
| 9 | Responsiveness to questions | Written, specific, consistent answers | Evasive or contradictory replies |
| 10 | Research-use terms | Explicit research-use-only statement | Claims about human outcomes |
The sections below take the checks in groups. The general reasoning behind them is in vetting a research peptide supplier, choosing a peptide supplier and red flags when buying research peptides.
Checks 1 to 4: what is in the vial
Identity on the page. A trustworthy product page states what the compound is in chemical terms. The V8 pages give a molecular formula and a sequence or identity note, the form supplied, the size and a purity specification. For example, the AOD-9604 page lists a 5 mg lyophilized powder with a formula, and the retatrutide page lists 10 mg and 20 mg sizes. If you cannot compare a formula against a reference, the page has not told you what you are buying.
The certificate. A certificate of analysis is only useful when tied to a lot number. Check that the number on the document matches the vial in hand, and look at the date. How to read the fields is explained in how to read a COA, and what independent testing means in third-party testing explained. The V8 COA library shows certificates where published, and states that each is specific to its lot.
What a purity number means. HPLC purity is the share of the detected signal that belongs to the main peak. It does not report net peptide content, water, counter-ions or biological activity, and different gradients can resolve different impurities. The quality-specification framework for synthetic peptides, set out by Vergote and colleagues (2009), separates identity, purity, content and impurity profile for exactly this reason. Understanding HPLC purity goes through the limits in more detail.
Identity as its own question. A clean chromatogram says there is one dominant species, not which species. Identity is established by a measurement tied to the molecule, usually its mass, and a good certificate reports it separately.
Checks 5 and 6: suitability for your assay
Different assays tolerate different contaminants. A cell-culture experiment is sensitive to endotoxin and to microbial contamination in a way that a chemical stability study is not, so ask whether endotoxin and sterility results are reported for the lot. Form and storage matter too. Lyophilized powder is the most stable state, and Manning and colleagues (2010) review why peptides and proteins degrade by oxidation, deamidation and aggregation once in solution. The V8 pages list refrigeration at 2–8 °C, −20 °C for long-term storage and protection from heat, moisture and light; the lyophilized form is explained in what is lyophilization and handling in storing research peptides.
Checks 7 and 8: consistency and verifiability
Compare three documents: the product page, the label on the vial and the certificate. Name, size, lot number and storage text should agree. Differences are not always errors, but they are always questions. Then ask whether the testing source can be identified and the report checked. A certificate whose laboratory cannot be named, or one distributed only as an image with no lot number, offers little assurance. Where a supplier publishes certificates lot by lot, note which lots have them and which do not, and do not assume an unpublished lot has one. Seller-side statements such as "tested" or "verified" are claims; the report itself is the evidence.
Checks 9 and 10: communication and terms
Send one specific written question before ordering, for example how the stated purity was measured for a named compound, or whether a lot-specific certificate is available. The quality of the reply is informative: it should be specific, consistent with the product page and free of promises about outcomes. Finally, read the terms. A research supplier should state plainly that products are for laboratory research use only. Language that implies use in people, results in people or comparison with medicines is a reason to walk away. The regulatory background is summarized neutrally in research peptide legal status in the US.
A scoring sheet you can keep
| Item | Pass | Partial | Fail |
|---|---|---|---|
| Identity stated (formula/sequence) | Both given | One given | Neither |
| Lot-specific certificate | Matches lot | Present, different lot | None |
| Purity method disclosed | Method and conditions | Method only | Number only |
| Identity measurement reported | Yes | Implied | No |
| Endotoxin or sterility (if relevant) | Reported | On request | Unavailable |
| Storage stated | Temperature, light, moisture | Temperature only | None |
| Documents consistent | All agree | Minor differences explained | Unexplained mismatch |
| Testing source identifiable | Yes | Partly | No |
| Written reply to a specific question | Specific, consistent | Generic | Evasive |
| Research-use-only terms | Explicit | Implied | Missing or contradicted |
Any fail on checks 2, 3 or 10 is a reason to stop, because they bear directly on whether the data from the experiment will be interpretable. Record the scores with the order and keep them with the lot paperwork; the same sheet shows quickly whether a repeat supplier has drifted.
Worked example: comparing two hypothetical listings
Suppose two listings offer the same compound. Listing A gives the compound name, a formula, the form and size, a storage line, and a link to a certificate carrying a lot number and a date; the purity statement names HPLC. Listing B gives a brand-style name and the claim "99% pure, lab tested", with no formula, no certificate and no storage line. On the scoring sheet, A scores pass on identity, certificate, method and storage, and B fails on all four. Cost does not change the comparison, because B's data cannot be used whatever it costs: if the experiment later gives an odd result, there is nothing in B's documentation to rule the material in or out as the cause. The same logic applies to a middle case in which a certificate exists but its lot number differs from the vial. That scores partial, and the right response is a written question to the seller, not a decision made by guesswork.
Keeping the evidence together
For each purchase, store one folder or page with the product page capture, the certificate, a photo of the label, the receiving date, the storage location, the reconstitution date and diluent and the scoring sheet. When results are later questioned by a collaborator or reviewer, that folder answers the first three questions straight away: what the material was, how pure it was shown to be, and how it was handled. It also makes repeat purchases faster, because you can compare the new lot's documents with the previous ones and notice differences in method, laboratory or reported values.
After the order arrives
Verification does not end at checkout. On receipt, check the seal, the label against the certificate and the appearance of the powder against what a normal lyophilized cake looks like (see peptide vial appearance: what is normal), then log the lot and store it at the stated temperature. Work out concentrations from the formula mass divided by volume and use the reconstitution calculator for the arithmetic. Peptide drug quality and discovery context are surveyed by Muttenthaler and colleagues (2021) and Wang and colleagues (2022). Related compound-level material is in the semaglutide and tirzepatide buyer guide, and the full catalog is at the shop.
Frequently asked questions
What is the single most important document to check?
A lot-specific certificate of analysis whose lot number matches the vial. Without that link, a purity figure cannot be tied to the material you actually hold.
What does an HPLC purity percentage tell me?
The share of the detected signal that belongs to the main peak under the stated conditions. It does not give net peptide content, water, salt content or activity.
Is purity the same as identity?
No. A chromatogram shows how many species are present and their proportions. Identity is shown by a separate measurement, usually of mass, that matches the expected molecule.
Why do endotoxin and sterility results matter?
Cell-culture and some in vitro assays are sensitive to endotoxin and microbial contamination, so those results indicate whether a lot suits the assay.
How is agreement between certificate and vial checked?
Compare compound name, size and lot number on the label with the certificate and the product page. Any unexplained difference is a reason to ask the seller before using the material.
What storage conditions should a seller state?
At minimum the storage temperature and protection from light and moisture. The V8 pages list refrigeration at 2–8 °C and −20 °C for long-term storage.
Where does V8 publish certificates?
Certificates are published where available and are lot-specific; the COA library shows which are online. Check the page for the lot you hold instead of assuming.
What is a sign a supplier is not research-only?
Language about effects in people, comparison with medicines or advice on personal use. A research supplier should state laboratory research use only.
Is a scoring sheet worth keeping?
A simple pass, partial or fail sheet for each of the ten checks makes comparisons consistent and lets you spot drift between orders.
What if the answers to my written question are evasive?
Count that as a fail on responsiveness. Choose a supplier whose written answers are specific and agree with its product page.
Related reading: How to Choose Research Peptides in 2026: By Question, Peptides in Aging Research: A 2026 Evidence Review, Peptides in Muscle Biology Research: Pathways and Models.
References
- Vergote V, Burvenich C, Van de Wiele C, De Spiegeleer B. Quality specifications for peptide drugs: a regulatory-pharmaceutical approach. J Pept Sci. 2009;15(11):697-710. doi:10.1002/psc.1167
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. doi:10.1007/s11095-009-0045-6
- Muttenthaler M, King GF, Adams DJ, Alewood PF. Trends in peptide drug discovery. Nat Rev Drug Discov. 2021;20(4):309-325. doi:10.1038/s41573-020-00135-8
- Wang L, Wang N, Zhang W, et al. Therapeutic peptides: current applications and future directions. Signal Transduct Target Ther. 2022;7:48. doi:10.1038/s41392-022-00904-4
- Fosgerau K, Hoffmann T. Peptide therapeutics: current status and future directions. Drug Discov Today. 2015;20(1):122-128. doi:10.1016/j.drudis.2014.10.003
